Dynamic Technology Lab’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dynamic Technology Lab’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,870	Closed	-$695K	–	1252
2023 Q1	$695K	Buy	+2,870	New	+$782K	0.06%	512
2022 Q4	–	Sell	-3,150	Closed	-$205K	–	1349
2022 Q3	$205K	Sell	3,150 -220	-7%	-$15.3K	0.02%	955
2022 Q2	$241K	Buy	+3,370	New	+$248K	0.03%	850
2021 Q3	–	Sell	-2,230	Closed	-$217K	–	1318
2021 Q2	$217K	Buy	+2,230	New	+$264K	0.02%	911
2015 Q3	–	Sell	-353	Closed	-$28K	–	950
2015 Q2	$28K	Buy	+353	New	+$29.6K	0.01%	715

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Dynamic Technology Lab's MDGL Position: Q2 2023 in Review

Dynamic Technology Lab sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2023, closing a stake of 2,870 shares — an estimated $695K sold.

Dynamic Technology Lab first reported a position in MDGL in Q2 2015 and held it in 5 quarters. The position peaked at $695K in Q1 2023. 208 funds tracked by Wall St. Rank hold MDGL as of Q2 2023.

Dynamic Technology Lab reported no remaining Madrigal Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Dynamic Technology Lab sold 2,870 Madrigal Pharmaceuticals shares in Q2 2023, an estimated $695K.
Dynamic Technology Lab first reported a position in Madrigal Pharmaceuticals in Q2 2015 and held it in 5 quarters.
Dynamic Technology Lab's Madrigal Pharmaceuticals position peaked at $695K in Q1 2023.
208 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2023.

Based on Dynamic Technology Lab's 13F filing for Q2 2023, filed 14 Aug 2023.